- Home
- RAPT vs PEO Comparison
RAPT vs PEO Comparison
Compare RAPT & PEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- PEO
- Stock Information
- Founded
- RAPT 2015
- PEO 1929
- Country
- RAPT United States
- PEO United States
- Employees
- RAPT N/A
- PEO N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- PEO Finance/Investors Services
- Sector
- RAPT Health Care
- PEO Finance
- Exchange
- RAPT Nasdaq
- PEO Nasdaq
- Market Cap
- RAPT 498.4M
- PEO 577.0M
- IPO Year
- RAPT 2019
- PEO N/A
- Fundamental
- Price
- RAPT $29.86
- PEO $21.23
- Analyst Decision
- RAPT Strong Buy
- PEO
- Analyst Count
- RAPT 8
- PEO 0
- Target Price
- RAPT $46.75
- PEO N/A
- AVG Volume (30 Days)
- RAPT 614.9K
- PEO 35.4K
- Earning Date
- RAPT 11-11-2025
- PEO 01-01-0001
- Dividend Yield
- RAPT N/A
- PEO 5.93%
- EPS Growth
- RAPT N/A
- PEO N/A
- EPS
- RAPT N/A
- PEO N/A
- Revenue
- RAPT N/A
- PEO N/A
- Revenue This Year
- RAPT N/A
- PEO N/A
- Revenue Next Year
- RAPT N/A
- PEO N/A
- P/E Ratio
- RAPT N/A
- PEO N/A
- Revenue Growth
- RAPT N/A
- PEO N/A
- 52 Week Low
- RAPT $5.67
- PEO $19.22
- 52 Week High
- RAPT $42.39
- PEO $23.80
- Technical
- Relative Strength Index (RSI)
- RAPT 61.81
- PEO 47.60
- Support Level
- RAPT $25.50
- PEO $20.83
- Resistance Level
- RAPT $42.39
- PEO $21.35
- Average True Range (ATR)
- RAPT 3.91
- PEO 0.33
- MACD
- RAPT -0.18
- PEO -0.04
- Stochastic Oscillator
- RAPT 30.92
- PEO 43.64
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About PEO Adams Natural Resources Fund Inc.
Adams Natural Resources Fund Inc is a non-diversified U.S. equity fund that invests in liquid energy and other natural resources stocks. The Fund's investment objectives are preservation of capital, reasonable income, and opportunity for capital gain. A majority of its assets are invested in petroleum or natural resources industries or industries connected to them. It has broad flexibility to invest in stocks of varying capitalizations and predominantly invests in stocks found in the S&P 500 Energy and S&P 500 Materials sectors.